Abstract
Dawson-type heteropolyoxometalate compounds (HPC) P2M18O62 -6 (M= Mo, W) have received increasing attention in the catalytic field due to the combination of redox and acidic properties in the same structure. It has been proved that the introduction of vanadium into the Keggin framework is beneficial for redox catalysis, shifting its activity from acid to redox-dominated.
In this work we prepared and characterized vanadium (V) substituted Wells-Dawson heteropolysalt (WDKV). Fresh solid samples were characterized by 31P MAS-NMR, FTIR, SEM, XRD, TGA and Potentiometric titration measurements. Also, we performed the oxidation of a 1,4-dihydropyridine using WDKV as catalyst in acetonitrile media, with H2O2 as oxidant agent. The optimal procedure is the following: 1 mmol% of WDKV, a ratio 1,4-DHP: H2O2 (1:214) at reflux of acetonitrile. It must be noted that along all reactions, no secondary products were observed.
Keywords: Heteropolycompound, Oxidation, Hydrogen peroxide. 1, 4-dihydropyridine.
Current Catalysis
Title:Vanadium-Substituted Wells-Dawson Potassium Salt as Catalyst for Liquid phase Oxidation of 1,4-dihydropyridine Derivative
Volume: 3 Issue: 2
Author(s): Laura M. Sanchez, Angel G. Sathicq, Graciela T. Baronetti and Horacio J. Thomas
Affiliation:
Keywords: Heteropolycompound, Oxidation, Hydrogen peroxide. 1, 4-dihydropyridine.
Abstract: Dawson-type heteropolyoxometalate compounds (HPC) P2M18O62 -6 (M= Mo, W) have received increasing attention in the catalytic field due to the combination of redox and acidic properties in the same structure. It has been proved that the introduction of vanadium into the Keggin framework is beneficial for redox catalysis, shifting its activity from acid to redox-dominated.
In this work we prepared and characterized vanadium (V) substituted Wells-Dawson heteropolysalt (WDKV). Fresh solid samples were characterized by 31P MAS-NMR, FTIR, SEM, XRD, TGA and Potentiometric titration measurements. Also, we performed the oxidation of a 1,4-dihydropyridine using WDKV as catalyst in acetonitrile media, with H2O2 as oxidant agent. The optimal procedure is the following: 1 mmol% of WDKV, a ratio 1,4-DHP: H2O2 (1:214) at reflux of acetonitrile. It must be noted that along all reactions, no secondary products were observed.
Export Options
About this article
Cite this article as:
Sanchez M. Laura, Sathicq G. Angel, Baronetti T. Graciela and Thomas J. Horacio, Vanadium-Substituted Wells-Dawson Potassium Salt as Catalyst for Liquid phase Oxidation of 1,4-dihydropyridine Derivative, Current Catalysis 2014; 3 (2) . https://dx.doi.org/10.2174/2211544702666131224233041
DOI https://dx.doi.org/10.2174/2211544702666131224233041 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of Thymol Microsponges Loaded <i>in situ</i> Gel for the Treatment of Periodontitis
Current Drug Delivery Role of Gut Microbiota in Human Health and Diseases
Current Nutrition & Food Science Chronic Diseases and COVID-19: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF): Surgical Adjuvants, Preparations for In Situ Regenerative Medicine and Tools for Tissue Engineering
Current Pharmaceutical Biotechnology The Cathelicidins - Structure, Function and Evolution
Current Protein & Peptide Science Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks
Current Pharmaceutical Design Treating Dyslipidemias: Is Inflammation the Missing Link?
Medicinal Chemistry Potential Replication of Induced Pluripotent Stem Cells for Craniofacial Reconstruction
Current Stem Cell Research & Therapy The Role of Recombinant Human Platelet-derived Growth Factor-BB (rhPDGF-BB) in Orthopaedic Bone Repair and Regeneration
Current Pharmaceutical Design Novel Strategies to Delineate Matrix Metalloproteinase (MMP)-Substrate Relationships and Identify Targets to Block MMP Activity
Mini-Reviews in Medicinal Chemistry The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry Preface
Current Pharmaceutical Biotechnology Toll-like Receptor 4 Gene Polymorphisms in Chinese Population After Allogeneic Hematopoietic Stem Cell Transplantation
Current Bioinformatics The Infectious Etiology of Alzheimer’s Disease
Current Neuropharmacology Green Tea from the Far East to the Drug Store: Focus on the Beneficial Cardiovascular Effects
Current Pharmaceutical Design Bioisosters of β-Lactams as Anti-Infectives
Current Medicinal Chemistry - Anti-Infective Agents Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics
Mini-Reviews in Medicinal Chemistry Antimicrobial Peptides in Oral Cancer
Current Pharmaceutical Design Safety of Inhaled Fluticasone Propionate Therapy for Pediatric Asthma - A Systematic Review
Current Drug Safety Therapeutic Implications of Superoxide Dismutase And Its Importance in Kinase Drug Discovery
Current Topics in Medicinal Chemistry